Russell Investments Boosts Johnson & Johnson Stake by 11.7%

Investment firm adds over 288,000 shares of healthcare giant in Q3

Mar. 9, 2026 at 11:08am

Got story updates? Submit your updates here. ›

Russell Investments Group Ltd. grew its position in shares of Johnson & Johnson (NYSE:JNJ) by 11.7% during the third quarter, according to a recent SEC filing. The investment firm now owns over 2.75 million shares of the pharmaceutical company, worth approximately $508 million.

Why it matters

Johnson & Johnson is a bellwether stock in the healthcare sector, and institutional investor activity in the company's shares is closely watched by the market. Russell Investments' increased stake signals continued confidence in J&J's long-term prospects among major institutional investors.

The details

According to the filing, Russell Investments acquired an additional 288,137 shares of Johnson & Johnson during the third quarter. This increased the firm's total position to 2,751,532 shares, or about 0.11% of the company's outstanding stock. Russell Investments is now one of J&J's larger institutional shareholders.

  • Russell Investments filed the 13F report disclosing the increased stake on March 9, 2026.

The players

Russell Investments Group Ltd.

A global asset management firm that oversees over $300 billion in client assets.

Johnson & Johnson

A multinational pharmaceutical and medical devices company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

The takeaway

Russell Investments' increased position in Johnson & Johnson underscores the healthcare giant's appeal as a defensive, dividend-paying blue chip stock among major institutional investors. The move suggests confidence in J&J's ability to weather market volatility and continue delivering steady returns for shareholders.